Multidisciplinary Team Meetings in Thoracic Oncology: An Update on the Evidence, Limitations, and Future Perspectives

Multidisciplinary team (MDT) meetings are now a central component of contemporary thoracic oncology care.Lung cancer remains a major cause of cancer-related mortality, and its management involves increasingly complex decisions integrating accurate disease staging, comprehensive biomarker testing, and multimodal treatment strategies.This review synthesizes the published evidence on the impact of MDTs in thoracic oncology, discusses their methodological and organizational limitations, and analyzes recent developments: molecular tumor boards, virtual MDTs and telemedicine, quality indicators, artificial intelligence (AI) tools, and patient-centered decision-making.The literature is predominantly observational and retrospective; a systematic review of 29 lung cancer studies identified only one randomized trial.Overall, observational studies suggest that MDT discussion is associated with a greater likelihood of receiving active treatment and guideline-concordant care.Findings regarding survival are heterogeneous, and the available evidence does not establish an independent causal effect of MDT discussion on survival.The main weaknesses are heterogeneity of recommendations between centers, discordance between recommended and delivered treatment, time and resource burden, incomplete documentation of conclusions, and frequent lack of explicit consideration of patient preferences.Based on the current literature, the most promising proposed priorities for further evaluation include structured performance indicators, standardized documentation, wider adoption of hybrid meeting formats, and the integration of AI positioned as a decision support tool rather than an autonomous decision-maker.However, while these approaches identify potential areas for improvement, further research is required to conclusively establish their effectiveness on clinical patient outcomes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119620
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multidisciplinary Team Meetings in Thoracic Oncology: An Update on the Evidence, Limitations, and Future Perspectives

Narriman Laouar, Leila Laouar
Cureus
Lung Cancer Diagnosis and Treatment
article

Multidisciplinary Team Meetings in Thoracic Oncology: An Update on the Evidence, Limitations, and Future Perspectives

Narriman Laouar, Leila Laouar
article en

Abstract

Multidisciplinary team (MDT) meetings are now a central component of contemporary thoracic oncology care.Lung cancer remains a major cause of cancer-related mortality, and its management involves increasingly complex decisions integrating accurate disease staging, comprehensive biomarker testing, and multimodal treatment strategies.This review synthesizes the published evidence on the impact of MDTs in thoracic oncology, discusses their methodological and organizational limitations, and analyzes recent developments: molecular tumor boards, virtual MDTs and telemedicine, quality indicators, artificial intelligence (AI) tools, and patient-centered decision-making.The literature is predominantly observational and retrospective; a systematic review of 29 lung cancer studies identified only one randomized trial.Overall, observational studies suggest that MDT discussion is associated with a greater likelihood of receiving active treatment and guideline-concordant care.Findings regarding survival are heterogeneous, and the available evidence does not establish an independent causal effect of MDT discussion on survival.The main weaknesses are heterogeneity of recommendations between centers, discordance between recommended and delivered treatment, time and resource burden, incomplete documentation of conclusions, and frequent lack of explicit consideration of patient preferences.Based on the current literature, the most promising proposed priorities for further evaluation include structured performance indicators, standardized documentation, wider adoption of hybrid meeting formats, and the integration of AI positioned as a decision support tool rather than an autonomous decision-maker.However, while these approaches identify potential areas for improvement, further research is required to conclusively establish their effectiveness on clinical patient outcomes.

Cureus
Hôpital Mustapha Pacha (DZ)
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon